Company profile: Nexus Biosystems
1.1 - Company Overview
Company description
- Provider of technologies and automation systems for pharmaceutical, biotech, agrochemical, and academic research institutions internationally, offering Universal Store, a sample storage and retrieval system, and IRORI technologies for directed sorting and cleaving of solid-phase combinatorial.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nexus Biosystems
Devana Solutions
HQ: United States
Website
- Description: Provider of SaaS solutions that connect research sites with sponsors and CROs to reduce drug development costs through data transparency and selection of top-performing sites. PROPEL supports trial opportunity tracking and real-time collaboration; CENTRAL enables startup automation, pipeline and trial tracking, workflow automation, customizable dashboards; ENTERPRISE adds advanced collaboration, site capability queries, and comprehensive profiles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Devana Solutions company profile →
Clarivate
HQ: United States
Website
- Description: Provider of trusted insights, analytics, data, workflow solutions, and deep domain expertise that help innovators discover, protect, and commercialize ideas faster. Offers real-world healthcare data, formulary tools, patient identification and assistance, and consulting in commercial strategy, evidence/value/access, and technology, including systems integration, data informatics, and custom solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clarivate company profile →
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Author-it company profile →
Dana Solutions
HQ: United States
Website
- Description: Provider of applications of artificial intelligence and machine learning to in vitro cell-based assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dana Solutions company profile →
Neem Biotech
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in pilot- to industrial-scale extraction of bio-active compounds from plant and marine sources to high-purity levels. Based in Cardiff, United Kingdom; incorporated in 1998 and, since July 20, 2012, operating as a subsidiary of InQpharm Group.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neem Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nexus Biosystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nexus Biosystems
2.2 - Growth funds investing in similar companies to Nexus Biosystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nexus Biosystems
4.2 - Public trading comparable groups for Nexus Biosystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →